The Lancet - Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

The Lancet -  Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

https://www.thelancet.com/lancet/article/s0140-6736(20)31604-4

21 de julho de 2020

Categorias

Categorias

Arquivo de Notícias

Arquivo